Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Small study aims to perfect fluid dosing for safer C-Sections

NCT ID NCT07324512

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing different amounts of IV fluid given during spinal anesthesia for planned C-sections to find the smallest dose that prevents dangerously low blood pressure in 90% of women. 45 healthy pregnant women at term will receive a specific fluid volume right after the spinal injection, and the dose will be adjusted for each next participant based on results. The goal is to improve safety for both mother and baby without using more fluid than needed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intravenous crystalloid fluid (balanced salt solution)
What this could lead to
If successful, this could establish a standard fluid dose to prevent dangerous drops in blood pressure during C-sections, making the procedure safer for mothers and newborns.
What could go wrong
This is a very small, early-phase dose-finding study (45 participants) with no comparison group. Results may not apply to all pregnant women, and the optimal dose may still fail in some cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant adults ≥19 years scheduled for elective cesarean delivery under spinal anesthesia * Term pregnancy (≥37 weeks' gestation) Exclusion Criteria: * Emergency cesarean delivery * Hypertensive disorders of pregnancy (preeclampsia/eclampsia) or hypertension * Multiple gestation * Body weight \<50 kg or BMI \>35 kg/m² * Renal impairment or eGFR ≤90 mL/min/1.73 m² * Heart failure or other heart disease * History of bronchial asthma or other pulmonary disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal induced hypotension in cesarean delivery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.